🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
The purpose of this study is to evaluate the safety, pharmacokinetics (PK),...
Status
Completed
Location
Research Facility
Start Date
2004-08
Trial ID
NCT00097747
Treatments Being Tested
This single arm study will assess the efficacy and safety of subcutaneous M...
Status
Terminated
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00462384
Treatments Being Tested
The main purpose of this study is to see if pegfilgrastim (Neulasta) is saf...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2003-07
Trial ID
NCT00146562
Treatments Being Tested
The primary objective was to assess the superiority of darbepoetin alfa ver...
Status
Completed
Location
Research Site
Start Date
2011-12-21
Trial ID
NCT01362140
Treatments Being Tested
EPOMI is a randomized, open-label, parallel phase II clinical study that wi...
Status
Completed
Location
CHU Angers
Start Date
2008-04
Trial ID
NCT00648089
Treatments Being Tested
This study employs a multicenter, randomized, open-label, positive drug-con...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06854276
This study will assess the efficacy and safety of methoxy polyethylene glyc...
Status
Terminated
Location
Multiple Locations
Start Date
2007-04
Trial ID
NCT00454246
Treatments Being Tested
This is an open-label, multicenter pharmacokinetic study of Hemodialysis (H...
Status
Completed
Location
Multiple Locations
Start Date
2002-06-05
Trial ID
NCT00239616
Treatments Being Tested
The purpose of the study is to evaluate the effect of Zinc supplementation ...
Status
Completed
Location
National Institute of Urology and Nephrology
Start Date
2014-12
Trial ID
NCT02335593